Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2007-06-19
2007-06-19
Saoud, Christine J. (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S388100, C530S388150, C530S387700, C530S387100, C530S391100, C530S391300
Reexamination Certificate
active
10063517
ABSTRACT:
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
REFERENCES:
patent: 5536637 (1996-07-01), Jacobs
patent: 6025156 (2000-02-01), Gwynn et al.
patent: 6124433 (2000-09-01), Falb et al.
patent: 6156500 (2000-12-01), Falb
patent: 6162604 (2000-12-01), Jacob
patent: 6228582 (2001-05-01), Rodier et al.
patent: 6395306 (2002-05-01), Cui et al.
patent: 6414117 (2002-07-01), Levinson
patent: 6465185 (2002-10-01), Goldfine et al.
patent: 6498235 (2002-12-01), Sheppard et al.
patent: 6562343 (2003-05-01), Levinson
patent: 6645499 (2003-11-01), Lal et al.
patent: 6730502 (2004-05-01), Van Hijum et al.
patent: 6737522 (2004-05-01), Sundick et al.
patent: WO 97/38085 (1997-10-01), None
patent: WO 01/16318 (2001-03-01), None
patent: WO 01/29221 (2001-04-01), None
Gygi et al. Mol. Cell. Biol. 1720-1730, 1999.
Hu et al. J. Proteome Res. 2: 405-412, 2003.
Pennica et al. Proc. Natl. Acad. Sci. USA 95: 14717-14722, 1998.
Hittelman. Ann,. NY Acad. Sci. 952: 1-12, 2001.
Fessler et al. A genomic and proteomic analysis of activation of the human neutrophil by lipopolysaccharide and its mediation by p38 mitogen-activated protein kinase. J. Biol. Chem. 277(35): 31291-31302, Aug. 2002.
Saito-Hisamintato et al. DNA Res. 9: 35, 2002.
Celis et al. FEBS Lett. 480: 2-16, 2000.
Heddwen et al. cDNA array identification of genes regulated in rat medulla in response to vasopressin infusion. Am. J. Physiol. Renal Physiol. 284: F218-F228, 2003.
Berner et al. Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas. Histopathology 42: 546-554, 2003.
Toler et al. Loss of communication in ovarian cancer. Am J. of Obs. Gyn. 194: e27-e31, 2006.
Sugg et al. Cytoplasmic staining of erB-2 but not mRNA levels correlates with differentiation in human thyroid neoplasia. Clinical Endocrinol. 49: 629-637, 1998.
Oda et al. Expression of MDR1/-glycoprotein and multidrug resistance-associated protein in childhood solid tumours. Virchows Arch. 430: 99-105, 1997.
Klein, et al. Selection for Genes Encoding Secreted Proteins and Receptors.Proc. Natl. Acad. Sci., 93: 7108-7113 (1996).
Alberts, et al. 1994.Molecular Biology of the Cell, 3rd Edition, pp. 403-404, 453. New York: Garland Publishing.
Alberts, et al. 2002.Molecular Biology of the Cell 4th Edition, pp. 302, 363-364, 379, 435. New York: Garland Publishing.
Allman, et al. 1996. BCL-6 Expression During B-Cell Activation.Blood. 87 (12): 5257-5268.
Chen, et al. 2002. Discordant Protein and mRNA Expression in Lung Adenocarcinomas.Molecular&Cellular Proteomics. 1.4: 304-313.
Grimaldi, et al. 1989. The t(5;14) chromosomal translocation in a case of acute lymphocytic leukemia joins the interleukin-3 gene to the immunoglobulin heavy chain gene.Blood, 73(8):2081-2085.
Hanna, et al. Aug. 1999. HER-2
eu breast cancer predictive testing.Pathology Associates Medical Laboratories.
Hyman et al. Nov. 2002. Impact of DNA Amplification of Gene Expression Patterns.Cancer Research, 62:6240-6245.
Lewin, B. 1994. Oncogenes: Gene Expression and Cancer, Chap. 39, pp. 1196-1201.Genes V. New York: Oxford University Press.
Lewin, B. 1997. Regulation of Transcription, Chap. 29, pp. 847-848.Genes VI. New York: Oxford University Press.
Meeker, et al. 1990. Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosionophilia.Blood, 76(2):285-289.
Meric, et al. 2002. Translation initiation in cancer: A novel target for therapy.Molecular Cancer Therapeutics, 1:971-979.
Ohara, et al. 2001. Directional cDNA library contruction assisted by the in vitro recombination reaction.Nucleic Acids Research. 29(4): 1-8.
Ørntoft, et al. 2002. Genome-wide study of gene copy numbers, transcripts, and protein levels in pairs of non-invasive and invasive human transitional cell carcinomas.Molecular&Cellular Proteomics, 1:37-45.
Pollack, et al. 2002. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors.PNAS, 99(20):12963-12968.
Singeleton, et al. 1992. Clinical and pathologic significance of the c-erbB-2 (HER-2
eu) oncogene.Pathol. Annu, 1(27):165-190.
Zhigang, et al. 2004. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues and its potential role in prostate carcinogenesis and progression of prostate cancer.World Journal of Surgical Oncology, 2:13.
Fu, et al. 1996. Translational regulation of human p53 gene expression.The EMBO Journal, vol. 15, No. 16, pp. 4392-4401.
Gökmen-Polar, et al., Feb. 2001, Elevated Protein Kinase C βll Is an Early Promotive Event in Colon Carcinogenesis,Cancer Research, vol. 61, pp. 1375-1381.
Hanash, S. 2003. Making sense of microarray data to classify cancer.The Pharmacogenomics Journal, 3:308-311.
Hanash, S. Mar. 2005. Integrated global profiling of cancer,Nature Reviews, Applied Proteomics Collection, pp. 9-14.
Hancock, W. S. 2004. Do We Have Enought Biomarkers?Journal of Proteome Research, 3(4):685.
Haynes, et al., 1998. Proteome analysis: Biological assay or data archive?Electrophoresis, vol. 19, pp. 1862-1871.
Jang A. Hill RP, Sep. 1997. An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-genes in murine tumor cells.Clin. Exp. Metastasis 15(5): pp. 469-483.
Konopka, et al. Jun. 1986. Variable Expression of the Translocated c-abl Oncogene in Philadelphia-Chromosome-Positive B-Lymphoid Cell Lines from Chronic Myelogenous Leukemia Patients,National Academy of Sciences of the United States of America, vol. 83, No. 11, pp. 4049-4052.
Powell, et al. Oct. 1998. Expression of cytochrome P4502E1 in human liver: assessment by mRNA, genotype and phenotype.Pharmacogenetics, vol. 5: pp. 411-421.
Vallejo, et al. Dec. 2000. Evidence of tissue-specific, post-transcriptional regulation of NRF-2 expression.Biochimie82(12): 1129-33.
Wang, et al. 1996. mRNA Differential display: Application in the discovery of novel pharmacological targets.Trends Pharmacol. Sci., 17(8):276-279.
Anderson, et al. 1997. A comparison of selected mRNA and protein abundances in human liver.Electrophoresis, 18:533.
Labaer, Joshua. 2003. Letter to the editor: Mining the literature and large datasets.Nature Biotechnology, 21(9):976.
Lian, et al. 2001. Genomic and proteomic analysis of the myeloid differential program.Blood, 98(3):513.
Lichtinghagen, et al. 2002. Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue.European Urology, 42:398.
Tokunaga, et al. 2000. Application of quantitative RT.
Valle, et al. 2003. New approaches for biomarker discovery in lung cancer.Expert Rev. Mol. Diagn. 3(1), 55.
Wang, et al. 2002 Novel candidate tumor marker genes for lung adenocarcinoma.Oncogene, 21:7598.
Yousef, et al. 2003. Parallel overexpression of seven kallikrein genes in ovarian cancer.Cancer Research, 63:2223.
2002-2003 Catalog & Technical Reference, New England BioLabs, Inc., p. 122.
Abe, et al. “An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue.”Br J Cancer. Dec. 1, 2003;89(11):2104-9. (Abstract Only).
Ando, et al. “Selective apoptosis of natural killer-cell tumours by I-asparaginase.”Br. J. Haematol. Sep. 2005;130(6):860-8. (Abstract Only).
Aust, et al. “Human thyroid carcinoma cell lines and normal thyrocytes: expression and regulation of matrix metalloproteinase-1 and tissue matrix metalloproteinase inhibitor-1 messenger-RNA and protein.”Thyroid. Oct. 1997;7(5):713-24. (Abstract Only).
Barnes, et al. “Expression of embryonic
Goddard Audrey
Godowski Paul J.
Grimaldi J. Christopher
Gurney Austin L.
Wood William I.
Barnes Elizabeth M.
Genentech Inc.
Knobbe Martens Olson & Bear LLP
Kresnak Mark T.
Saoud Christine J.
LandOfFree
PRO300 antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with PRO300 antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PRO300 antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3838549